| Stock | Role | Class | Num Shares | Value | Price $ | Report Date | Ownership |
|---|---|---|---|---|---|---|---|
| Perspective Therapeutics, Inc. | CEO, Director | Common Stock | 36.3K | $137K | $3.77 | Dec 4, 2024 | Direct |
| Perspective Therapeutics, Inc. | CEO, Director | Common Stock | 12.6K | $47.5K | $3.77 | Dec 4, 2024 | By IRA of Spouse |
| Perspective Therapeutics, Inc. | CEO, Director | Common Stock | 5.4K | $20.3K | $3.77 | Dec 4, 2024 | By IRA of Reporting Person |
| Perspective Therapeutics, Inc. | CEO, Director | Common Stock | 1K | $3.77K | $3.77 | Dec 4, 2024 | By Child |
| Perspective Therapeutics, Inc. | CEO, Director | Stock option (right to buy) | 500K | Jun 20, 2024 | Direct |
| Symbol | Company | Period | Transactions | Value $ | Form Type | Date Filed | Role |
|---|---|---|---|---|---|---|---|
| CATX | Perspective Therapeutics, Inc. | Dec 4, 2024 | 1 | $30.1K | 4 | Dec 4, 2024 | CEO, Director |
| CATX | Perspective Therapeutics, Inc. | Nov 25, 2024 | 0 | $0 | 4/A | Dec 4, 2024 | CEO, Director |
| CATX | Perspective Therapeutics, Inc. | Jun 20, 2024 | 1 | $0 | 4 | Jun 24, 2024 | CEO, Director |
| CATX | Perspective Therapeutics, Inc. | Jun 13, 2024 | 1 | $117K | 4 | Jun 13, 2024 | CEO, Director |
| CATX | Perspective Therapeutics, Inc. | Dec 12, 2023 | 1 | $0 | 4 | Dec 14, 2023 | CEO, Director |
| CATX | Isoray, Inc. | Feb 3, 2023 | 0 | $0 | 3 | Feb 13, 2023 | CEO, Director |